15,989
Views
35
CrossRef citations to date
0
Altmetric
Review

Dengue in the elderly: a review

ORCID Icon, &
Pages 729-735 | Received 29 Mar 2017, Accepted 19 Jul 2017, Published online: 28 Jul 2017

References

  • Brady OJ, Gething PW, Bhatt S, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6:8.
  • Saya. WHO |Dengue. [cited 2017 Jan 14]. Available from: http://www.who.int/topics/dengue/en/
  • Mayer SV, Tesh RB, Vasilakis N. The emergence of arthropod-borne viral diseases: a global prospective on dengue, chikungunya and zika fevers. Acta Trop. 2017;166:155–163.
  • Huang S-Y, Lee I-K, Wang L, et al. Use of simple clinical and laboratory predictors to differentiate influenza from dengue and other febrile illnesses in the emergency room. BMC Infect Dis. 2014;14:623.
  • Ong A, Sandar M, Chen MI, et al. Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int J Infect Dis. 2007;11(3):263–267.
  • Guzman MG, Halstead SB, Artsob H, et al. Dengue : a continuing global threat Europe PMC Funders Author Manuscripts. Nat Rev Microbiol. 2010;8(120):S7–16.
  • World Health Organization (WHO) Regional Office for South-East Asia. Dengue: guidelines for diagnosis, treatment, prevention, and control. Spec Program Res Train Trop Dis. 2009:147. WHO/HTM/NTD/DEN/2009.1.
  • Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11(3):480–496.
  • Lee VJ, Lye DCB, Sun Y, et al. Predictive value of simple clinical and laboratory variables for dengue hemorrhagic fever in adults. J Clin Virol. 2008;42(1):34–39.
  • Guzman MG, Kouri GP, Bravo J, et al. Dengue haemorrhagic fever in cuba. I. Serological confirmation of clinical diagnosis. Trans R Soc Trop Med Hyg. 1984;78(2):235–238.
  • Rigau-Pérez JG, Vorndam AV, Clark GG. The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. Am J Trop Med Hyg. 2001;64(1–2):67–74.
  • Rahman M, Rahman K, Siddque AK, et al. Kamal A H AKS. First outbreak of dengue hemorrhagic fever, Bangladesh. Emerg Infect Dis. 2002;8:738–740.
  • Liu C, Huang K, Huang M, et al. High case-fatality rate of adults with dengue hemorrhagic fever during an outbreak in non-endemic Taiwan : risk factors for dengue-infected elders. Departments of Pediatrics, 2 Microbiology and Immunology, 3 Nursing, 4 Basic Medical Sciences, Emergency. 2008;4(1):10–17.
  • Kouri GP, Guzmán MG, Bravo JR, et al. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull World Health Organ. 1989;67(4):375–380.
  • Endy TP, Nisalak A, Chunsuttiwat S, et al. Spatial and temporal circulation of dengue virus serotypes: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol. 2002;156(1):52–59.
  • Teixeira MG, Siqueira JB, Ferreira GLC, et al. Epidemiological trends of dengue disease in Brazil (2000-2010): a systematic literature search and analysis. PLoS Negl Trop Dis. 2013;7:12.
  • Villar LA, Rojas DP, Besada-Lombana S, et al. Epidemiological trends of dengue disease in Colombia (2000-2011): a systematic review. PLoS Negl Trop Dis. 2015;9(3):1–16.
  • Dantés HG, Farfán-Ale JA, Sarti E. Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis. PLoS Negl Trop Dis. 2014;8:11.
  • Mohd-Zaki AH, Brett J, Ismail E, et al. Epidemiology of dengue disease in Malaysia (2000-2012): a systematic literature review. PLoS Negl Trop Dis. 2014;8(11):1–9.
  • Bravo L, Roque VG, Brett J, et al. Epidemiology of dengue disease in the Philippines (2000-2011): a systematic literature review. PLoS Negl Trop Dis. 2014;8(11). DOI:10.1371/journal.pntd.0003027
  • Limkittikul K, Brett J, L’Azou M. Epidemiological trends of dengue disease in Thailand (2000-2011): a systematic literature review. PLoS Negl Trop Dis. 2014;8(11). DOI:10.1371/journal.pntd.0003241
  • L’Azou M, Taurel A-F, Flamand C, et al. Recent epidemiological trends of dengue in the French territories of the Americas (2000–2012): a systematic literature review. Horstick O, ed. PLoS Negl Trop Dis. 2014;811:e3235. DOI:10.1371/journal.pntd.0003235
  • Ooi EE, Goh KT, Gubler DJ. Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis. 2006;12(6):887–893. DOI:10.3201/10.3201/eid1206.051210.
  • Ang LW, Cutter J, James L, et al. Seroepidemiology of dengue virus infection in the adult population in tropical Singapore. Epidemiol Infect. 2015;143(8):1585–1593.
  • Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. 2009;22(11):1041–1050.
  • Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis. 2005;41(Suppl 7):S504–12.
  • Lee CC, Hsu HC, Chang CM, et al. Atypical presentations of dengue disease in the elderly visiting the ED. Am J Emerg Med. 2013;31(5):783–787.
  • Rowe EK, Leo YS, Wong JGX, et al. Challenges in dengue fever in the elderly: atypical presentation and risk of severe dengue and hospita-acquired infection. PLoS Negl Trop Dis. 2014;8(4). DOI:10.1371/journal.pntd.0002777.
  • Low JGH, Ong A, Tan LK, et al. The early clinical features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl Trop Dis. 2011;5(5). DOI:10.1371/journal.pntd.0001191.
  • Lye DC, Lee VJ, Sun Y, et al. The benign nature of acute dengue infection in hospitalized older adults in Singapore. Int J Infect Dis. 2010;14(5):e410–3.
  • Lin C, Schiøler KL, Jepsen MR, et al. Dengue outbreaks in high-income area, Kaohsiung city, Taiwan. Emerg Infect Dis. 2012;18(10):2003–2009.
  • Vicente CR, Cerutti Junior C, Froschl G, et al. Influence of demographics on clinical outcome of dengue: a cross-sectional study of 6703 confirmed cases in Vitória, Espírito Santo State, Brazil. Epidemiol Infect. 2016;1–8. DOI:10.1017/S0950268816002004
  • Lee I-K, Liu J-W, Yang KD. Clinical and laboratory characteristics and risk factors for fatality in elderly patients with dengue hemorrhagic fever. Am J Trop Med Hyg. 2008;79(2):149–153.
  • Valero N, Mosquera J, Añez G, et al. Differential oxidative stress induced by dengue virus in monocytes from human neonates, adult and elderly individuals. PLoS One. 2013;8(9). DOI:10.1371/journal.pone.0073221
  • Rojas EM, Díaz-Quijano FA, Coronel-Ruiz C, et al. Correlación entre los niveles de glutatión peroxidasa, un marcador de estrés oxidativo, y la presentación clínica del dengue. Rev Med Chil. 2007;135(6):743–750.
  • Soundravally R, Sankar P, Bobby Z, et al. Oxidative stress in severe dengue viral infection: association of thrombocytopenia with lipid peroxidation. Platelets. 2008;19(6):447–454.
  • Seet RCS, Lee C-YJ, Lim ECH, et al. Oxidative damage in dengue fever. Free Radic Biol Med. 2009;47(4):375–380.
  • Thai KTD, Nishiura H, Hoang PL, et al. Age-specificity of clinical dengue during primary and secondary infections. PLoS Negl Trop Dis. 2011;5:6.
  • Htun NSN, Odermatt P, Eze IC, et al. Is diabetes a risk factor for a severe clinical presentation of dengue? - review and meta-analysis. PLoS Negl Trop Dis. 2015;9(4):1–18. DOI:10.1371/journal.pntd.0003741.
  • Toledo J, George L, Martinez E, et al. Relevance of non-communicable comorbidities for the development of the severe forms of dengue: a systematic literature review. PLoS Negl Trop Dis. 2016;10(1):1–18.
  • García-Rivera EJ, Rigau-Pérez JG, Garcia-Rivera EJ, et al. Dengue severity in the elderly in Puerto Rico. Rev Panam Salud Publica. 2003;13(6):362–368.
  • Leo Y-S, Thein TL, Fisher DA, et al. Confirmed adult dengue deaths in Singapore: 5-year multi-center retrospective study. BMC Infect Dis. 2011;11(1):123.
  • Guzmán MG, Kouri G, Bravo J, et al. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002;6(2):118–124.
  • Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–2963.
  • Organization WH. Handbook for Clinical Management of Dengue. 2012. [cited 2017 Mar 19]. Avaialble from: http://www.who.int/tdr/publications/handbook_dengue/en/.
  • Lee TH, Lee LK, Lye DC, et al. Current management of severe dengue infection. Expert Rev Anti Infect Ther. 2017;15(1):67–78.
  • Yacoub S, Wertheim H, Simmons CP, et al. Cardiovascular manifestations of the emerging dengue pandemic. Nat Rev Cardiol. 2014;11(6):335–345.
  • Thanachartwet V, Wattanathum A, Sahassananda D, et al. Dynamic measurement of hemodynamic parameters and cardiac preload in adults with dengue: a prospective observational study. PLoS One. 2016;11(5):e0156135. Huy NT, ed. DOI:10.1371/journal.pone.0156135
  • Lye DC, Archuleta S, Syed-Omar SF, et al. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial. Lancet. 2017;389(10079):1611–1618.
  • Unnikrishnan R, Faizal BP, Vijayakumar P, et al. Clinical and laboratory profile of dengue in the elderly. J Fam Med Prim Care. 2015;4(3):369–372.
  • Lum LHW, Chan M, Leo YS. Strategy in managing anticoagulation therapy following prosthetic heart valve replacement in a patient with dengue fever. Int J Cardiol. 2015;199:432–434.
  • Capeding MR, Tran NH, Hadinegoro SRS, et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014;384(9951):1358–1365.
  • Villar L, Dayan GH, Arredondo-García JL, et al. Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med. 2014;372(2):141103114505002.